Comparative efficacy of postoperative adjuvant transcatheter arterial chemoembolization and hepatic artery infusion chemotherapy in patients with BCLC stage 0-B hepatocellular carcinoma at high risk of recurrence following radical resection
In HCC patients with high-risk recurrence following radical resection, PA-HAIC significantly improves RFS compared to PA-TACE, but only in patients with MVI, tumor diameter ≥5 cm, or multiple tumors.
Authors
- Jue Yuan
- Yupei Ao
- Chun’an Tang (ORCID: https://orcid.org/0000-0001-8284-0211)
- Feng Xu (ORCID: https://orcid.org/0000-0003-0902-2858)
- Jiarui Liu (ORCID: https://orcid.org/0000-0003-1881-1971)
- Zheng‐Rong Shi
Institutions
- Dalian Medical University (CN)
- Second Affiliated Hospital of Chongqing Medical University (CN)
- Chongqing Maternal and Child Health Hospital (CN)
- The Affiliated Yongchuan Hospital of Chongqing Medical University (CN)
- First People's Hospital of Chongqing (CN)
- Chongqing Medical University (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-09-19
- DOI
- https://doi.org/10.3389/fphar.2025.1657794
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00